Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease: a novel diagnostic method
Aims The purpose of this study was to establish contrast-enhanced ultrasound perfusion imaging (CUPI) of the lower extremities as a novel non-invasive diagnostic tool for patients with peripheral arterial disease (PAD). Methods and results Ultrasound contrast agent (SonoVue™) was injected into a per...
Saved in:
Published in | European heart journal Vol. 27; no. 3; pp. 310 - 315 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.02.2006
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aims The purpose of this study was to establish contrast-enhanced ultrasound perfusion imaging (CUPI) of the lower extremities as a novel non-invasive diagnostic tool for patients with peripheral arterial disease (PAD). Methods and results Ultrasound contrast agent (SonoVue™) was injected into a peripheral vein of 16 control subjects and 16 PAD patients and its appearance in the calf muscle was detected by low-energy harmonic ultrasound. Analysis of the wash-in curves revealed that PAD patients had a significantly longer time to peak intensity (TTP), i.e. duration of maximum contrast perfusion [37 s (19–79 s) in control subjects vs. 56 s (32–104 s) in PAD patients at rest, age-adjusted P=0.002]. Exercise stress test of the calf muscle resulted in a decrease of the TTP, maintaining the significant difference in TTP between the groups [19 s (8–37 s) in control subjects vs. 32 s (18–48 s) in PAD patients after exercise, age-adjusted P=0.004]. Neither ankle-brachial index and TTP nor age and TTP showed a significant correlation. Conclusion CUPI reflects the regional blood circulation of the calf muscle. In this pilot study, PAD patients show a significantly longer TTP than control subjects. The clinical relevance of CUPI is topic of ongoing studies. |
---|---|
Bibliography: | ark:/67375/HXZ-FXB9KRJG-2 local:ehi636 href:ehi636 Corresponding author. Tel: +49 761 270 3401; fax: +49 761 270 3699. E-mail address: duerschmied@medizin.ukl.uni-freiburg.de istex:134494084732CDC9DDF7C9B05BC22092CD663DA6 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0195-668X 1522-9645 |
DOI: | 10.1093/eurheartj/ehi636 |